Exogenous pyruvate protects IMS32 Schwann cells from impairing the maturation process under hyperglycemia
The Journal of Physiological Sciences · 2026-11 · 76 (3) · 100104
DOI: 10.1016/j.jphyss.2026.100104 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Physiological Sciences, 2026-11. Verfasst von Hideji Yako und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Neuroscience and Neurology, Tokyo University of Pharmacy and Life Sciences, Horinouchi, Hachioji, Tokyo, 192-0392, Japan; Lab…. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Core Research for Evolutional Science and Technology, Government of Japan Ministry of Health Labour and Welfare, Japan Science and Technology Agency.
Abstract (Originalsprache)
Peripheral neuropathy is a chronic common complication of diabetes mellitus. Continuous hyperglycemia induces metabolic disturbances and elicits oxidative stress. However, the impact of hyperglycemia on the maturation of Schwann cells is not fully understood. Therefore, we examined whether hyperglycemia affects the maturation process of IMS32 Schwann cells treated with forskolin, a Schwann cell maturation enhancer, using promoter assays and immunoblotting of Schwann cell markers such as MBP, CNPase, and GFAP. IMS32 cells exposed to high-glucose conditions showed decreased expression of these markers. Exogenous pyruvate plays a crucial role in maintaining glucose metabolism and reducing oxidative stress under hyperglycemic conditions. These decreases were prevented by pyruvate supplementation. Pyruvate treatment also prevented IMS32 cells from producing reactive oxygen species and from impairing mitochondrial membrane potential. These results indicate that hyperglycemia impairs Schwann cell maturation accompanied by mitochondrial dysfunction and oxidative stress, contributing to the development and progression of diabetic peripheral neuropathy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Molecular Neuroscience and Neurology, Tokyo University of Pharmacy and Life Sciences, Horinouchi, Hachioji, Tokyo, 192-0392, Japan; Laboratory for Drug Target Discovery, Tokyo University of Pharmacy and Li…
- Brain Metabolic Regulation Group Frontier Laboratory, Department of Psychiatry and Behavioral Sciences, Tokyo Metropolitan Institute of Medical Science, Tokyo, 156-8506, Japan.
Förderung
- Core Research for Evolutional Science and Technology
- Government of Japan Ministry of Health Labour and Welfare
- Japan Science and Technology Agency
- Ministry of Education, Culture, Sports, Science and Technology
- Japan Society for the Promotion of Science
- Takeda Science Foundation
Zitieren
APA
Yako, H., Hattori, S., Iwamoto, S., Ooki, T., Nagatani, W., Kaburaki, Y., Miyamoto, Y., Sango, K., & Yamauchi, J. (2026). Exogenous pyruvate protects IMS32 Schwann cells from impairing the maturation process under hyperglycemia. The Journal of Physiological Sciences, 76(3), 100104. https://doi.org/10.1016/j.jphyss.2026.100104
Vancouver
Yako H, Hattori S, Iwamoto S, Ooki T, Nagatani W, Kaburaki Y, et al. Exogenous pyruvate protects IMS32 Schwann cells from impairing the maturation process under hyperglycemia. The Journal of Physiological Sciences. 2026;76(3):100104. doi:10.1016/j.jphyss.2026.100104
BibTeX
@article{Yako2026,
author = {Yako, Hideji and Hattori, Sana and Iwamoto, Sayaka and Ooki, Tatsuya and Nagatani, Waraku and Kaburaki, Yuika and Miyamoto, Yuki and Sango, Kazunori and Yamauchi, Junji},
title = {Exogenous pyruvate protects IMS32 Schwann cells from impairing the maturation process under hyperglycemia},
journal = {The Journal of Physiological Sciences},
year = {2026},
volume = {76},
number = {3},
pages = {100104},
doi = {10.1016/j.jphyss.2026.100104}
}
EUVIMED